For individuals living with Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a debilitating condition, the arrival of this treatment and Attruby represents a significant breakthrough . These novel therapies preserve the transthyretin protein, preventing its harmful build-up and reducing the impact of the disease . Individuals are now experiencing po